Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg2+ method

Clinica Chimica Acta

Volumn 294, Issue 1-2, 2000, Pages 77-92

  Nauck, Matthias ^a,b   Rifai, Nader ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

High density lipoprotein; Lipoprotein cholesterol; Low density lipoprotein cholesterol

Indexed keywords

DEXTRAN SULFATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM ION; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; EDUCATION PROGRAM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

ADULT; CHOLESTEROL; CHOLESTEROL, LDL; CHYLOMICRONS; DEXTRAN SULFATE; FASTING; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAGNESIUM; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0034059659     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00250-8     Document Type: Article

References (23)

1. Law M.R., Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? Br. Med. J. 308:1994;367-372.
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
3. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. New Engl J Med. 335:1996;1001-1009.
4. National Cholesterol Education Program (NCEP). Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1333-445.
5. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis. 2:1992;113-156.
6. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
7. Bachorik P.S., Ross J.W. National Cholesterol Education Program recommendations for measurements of low-density lipoprotein cholesterol: executive summary. National Cholesterol Education Program Working Group on Lipoprotein Measurements. Clin. Chem. 41:1995;1414-1420.
8. Rifai N., Warnick G.R., McNamara J.R., Belcher J.D., Grinstead G.F., Frantz I.D. Jr. Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem. 38:1992;150-160.
9. Demacker P.N., Hijmans A.G., Brenninkmeijer B.J., Jansen A.P., van 't Laar A. Five methods for determining low-density lipoprotein cholesterol compared. Clin Chem. 30:1984;1797-1800.
10. Siekmeier R., März W., Gross W. Insufficient accuracy and specificity of polyanion precipitation methods for quantifying low-density lipoproteins. Clin Chem. 36:1990;2109-2113.
11. Harris N., Neufeld E.J., Newburger J.W., et al. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. Clin Chem. 42:1996;1182-1188.
12. Yu H.H., Ginsburg G.S., Harris N., Rifai N. Evaluation and clinical application of a direct low density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am J Cardiol. 80:1997;1295-1299.
13. Rifai N., Iannotti E., DeAngelis K., Law T. Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method. Clin Chem. 44:1998;1242-1250.
14. Sugiuchi H., Irie T., Uji Y., Ueno T., Chaen T., Uekama K., Okabe H. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate. Clin Chem. 44:1998;522-531.
15. Sugiuchi H., Uji Y., Okabe H., et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem. 41:1995;717-723.
16. Nauck M., März W., Jarausch J., et al. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Clin Chem. 43:1997;1622-1629.
17. Harris N., Galpchian V., Thomas J., Iannotti E., Law T., Rifai N. Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. Clin Chem. 43:1997;816-823.
18. Rifai N., Cole T.G., Ianotti E., et al. Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay. Clin Chem. 44:1998;1452-1458.
19. Cole T.G., Ferguson C.A., Gibson D.W. High-throughput beta-quantification methods. Atherosclerosis. 108:(Suppl.):1994;S191.
20. Passing H., Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II. J Clin Chem Clin Biochem. 22:1984;431-445.
21. Carey R.N., Garber C.C. Evaluation of methods. Kaplan L.A., Pesce A.J. Clinical chemistry: theory, analysis and correlation. 3rd ed. 1996;402-423 C.V. Mosby, St. Louis, MO.
22. Westgard J.O., Carey R.N., Wold S. Criteria for judging precision and accuracy in method development and evaluation. Clin Chem. 20:1974;825-833.
23. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New Engl J Med. 333:1995;1301-1317.